New York 2023-2024 Regular Session

New York Senate Bill S03518

Introduced
1/31/23  
Refer
1/31/23  
Refer
1/3/24  
Engrossed
1/30/24  

Caption

Enacts the manufacturer disclosure and transparency act requiring prescription drug manufacturers to notify the attorney general of arrangements between pharmaceutical manufacturers resulting in the delay of the introduction of generic medications.

Companion Bills

NY A00895

Same As Enacts the manufacturer disclosure and transparency act requiring prescription drug manufacturers to notify the attorney general of arrangements between pharmaceutical manufacturers resulting in the delay of the introduction of generic medications.

Previously Filed As

NY S00488

Enacts the manufacturer disclosure and transparency act requiring prescription drug manufacturers to notify the attorney general of arrangements between pharmaceutical manufacturers resulting in the delay of the introduction of generic medications.

NY A02289

Enacts the manufacturer disclosure and transparency act requiring prescription drug manufacturers to notify the attorney general of arrangements between pharmaceutical manufacturers resulting in the delay of the introduction of generic medications.

NY A00895

Enacts the manufacturer disclosure and transparency act requiring prescription drug manufacturers to notify the attorney general of arrangements between pharmaceutical manufacturers resulting in the delay of the introduction of generic medications.

NY SB00138

An Act Requiring Manufacturers Of Brand Name Prescription Drugs To Provide Samples Of Such Drugs To Manufacturers Of Generic Prescription Drugs.

NY SB00262

An Act Requiring Manufacturers Of Brand Name Prescription Drugs To Provide Samples Of Such Drugs To Manufacturers Of Generic Prescription Drugs.

NY SB00048

An Act Requiring Manufacturers Of Brand Name Prescription Drugs To Provide Samples Of Such Drugs To Manufacturers Of Generic Prescription Drugs.

NY SB00188

An Act Requiring Brand Name Prescription Drug Manufacturers To Provide Samples Of Brand Name Drugs To Generic Prescription Drug Manufacturers.

NY SB00641

An Act Requiring Manufacturers Of Brand-name Prescription Drugs To Provide Samples Of Such Drugs To Manufacturers Of Generic Prescription Drugs.

NY SF168

Excessive price increases by manufacturers prohibition to generic or off-patent drugs

NY HB3086

Relating to requirements for pharmaceutical drug manufacturers to report prescription drug costs.

Similar Bills

No similar bills found.